Last month, Benchmark announced the sale of Benchmark Genetics Ltd and Benchmark Genetics Norway AS to Starfish Bidco AS, a wholly owned subsidiary of Novo Holdings AS, for an enterprise value of up ...
A Sheffield-based aquaculture biotechnology company says it has been through a “transformational” year after selling one of ...
Global clinical trials market will reach $79,977.1 million by 2031, growing by 7.0% annually over 2022-2031, driven by the increasing number of clinical trials and increase in demand for novel ...
Though M&A deal value and volume both declined in biopharma in 2024 compared to the year prior, PwC analysts still believe ...
Taiwan says China sending largest naval fleet in years to region Request To Download Sample of This Strategic Report @ Highlighted with 99 tables and 79 figures, this 186-page report ?Asia Pacific ...
17hon MSN
Novo Nordisk parent’s huge manufacturing deal is one step closer to closing. Meanwhile, Nobel Prize winners urge senators to ...
Catalent (CTLT) stock rises on reports of imminent $16.5 billion sale to Novo Holdings with FTC approval and EU Commission ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
By far, the largest acquisition of 2024 was Novo Holdings' yet-to-be-closed buyout of manufacturer Catalent at $16.5 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback